(Q47258950)

12 January 2018

title

Remission of adult acute lymphocytic leukaemia with alemtuzumab (English)

1 reference

12 January 2018

1 reference

J P Laporte

1

1 reference

12 January 2018

F Isnard

2

1 reference

12 January 2018

L Garderet

3

1 reference

12 January 2018

L Fouillard

4

1 reference

12 January 2018

N-C Gorin

5

1 reference

12 January 2018

publication date

1 September 2004

1 reference

12 January 2018

published in

Leukemia

1 reference

12 January 2018

volume

18

1 reference

12 January 2018

issue

9

1 reference

12 January 2018

page(s)

1557-1558

1 reference

12 January 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403422

exact match

0 references

cites work

Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403422

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403422

Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403422

inferred from DOI database lookup

7 January 2021

based on heuristic

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403422

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2403422

1 reference

12 January 2018

PubMed ID

15229619

1 reference

12 January 2018